Cancer patients, n (%) | Fibroadenoma patients, n (%) | |||||
---|---|---|---|---|---|---|
rs1271572 | ERβ–positive | ERβ–negative | p value | ERβ–positive | ERβ–negative | p value |
GG | 226 (26.43) | 39 (4.56) | 205 (32.64) | 30 (4.78) | ||
GT | 350 (40.94) | 60 (7.02) | <0.001 | 266 (42.36) | 38 (6.05) | 0.93 |
TT | 122 (14.27) | 58 (6.78) | 79 (12.58) | 10 (1.59) | ||
GG | 226 (26.43) | 39 (4.56) | 205 (32.64) | 30 (4.78) | ||
GT+TT(T carrier) | 472 (55.20) | 118 (13.80) | 0.07 | 345 (54.94) | 48 (7.64) | 0.901 |